Personalis (NASDAQ:PSNL) Trading Up 6.7%

Personalis (NASDAQ:PSNL) was up 6.7% during trading on Friday . The stock traded as high as $18.60 and last traded at $18.05, approximately 244,296 shares changed hands during trading. A decline of 47% from the average daily volume of 463,305 shares. The stock had previously closed at $16.92.

Several research analysts recently commented on PSNL shares. CIBC started coverage on shares of Personalis in a research note on Monday, July 15th. They set an “outperform” rating and a $29.00 price objective for the company. Bank of America started coverage on shares of Personalis in a research note on Monday, July 15th. They set a “neutral” rating and a $27.00 price objective for the company. Morgan Stanley started coverage on shares of Personalis in a research note on Monday, July 15th. They set an “overweight” rating and a $28.00 price objective for the company. Oppenheimer started coverage on shares of Personalis in a research note on Monday, July 15th. They set an “outperform” rating and a $29.00 price objective for the company. Finally, Cowen started coverage on shares of Personalis in a research note on Monday, July 15th. They set an “outperform” rating for the company. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $28.25.

The firm has a 50 day moving average of $20.87.

Personalis (NASDAQ:PSNL) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($0.89) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.58). The company had revenue of $15.80 million for the quarter, compared to analysts’ expectations of $14.92 million. Personalis’s revenue for the quarter was up 79.5% on a year-over-year basis. As a group, sell-side analysts anticipate that Personalis will post -0.93 earnings per share for the current year.

In related news, Director Ken Ludlum bought 70,000 shares of the company’s stock in a transaction on Monday, June 24th. The shares were bought at an average price of $17.00 per share, with a total value of $1,190,000.00. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

A number of large investors have recently added to or reduced their stakes in PSNL. Point72 Hong Kong Ltd purchased a new stake in Personalis during the 2nd quarter worth approximately $109,000. Cubist Systematic Strategies LLC purchased a new stake in Personalis during the 2nd quarter worth approximately $177,000. SG Americas Securities LLC purchased a new stake in Personalis during the 2nd quarter worth approximately $228,000. Northern Trust Corp purchased a new stake in Personalis during the 2nd quarter worth approximately $352,000. Finally, Morgan Stanley purchased a new stake in Personalis during the 2nd quarter worth approximately $470,000. 4.06% of the stock is currently owned by institutional investors.

About Personalis (NASDAQ:PSNL)

Personalis, Inc operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics.

Recommended Story: What are trading strategies for the 52-week high/low?

Receive News & Ratings for Personalis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Personalis and related companies with MarketBeat.com's FREE daily email newsletter.